
Hormone Therapy for Prostate Cancer Fact Sheet - NCI
This fact sheet describes hormone therapy and its role in treating prostate cancer. Learn about the types of hormone therapy, how they are used, and possible side effects.
Hormone Therapy for Prostate Cancer - American Cancer Society
Hormone therapy is also called androgen deprivation therapy (ADT). The goal of this treatment is to reduce levels of male hormones, called androgens, in the body, or to stop them from fueling …
Hormone therapy for prostate cancer - Mayo Clinic
Jul 15, 2025 · Hormone therapy for prostate cancer is a treatment that lowers or blocks testosterone. This treatment also is called androgen deprivation therapy (ADT). Most prostate …
Darolutamide in Combination With Androgen-Deprivation Therapy …
Sep 16, 2024 · Androgen-deprivation therapy (ADT) has been the standard of care for patients with metastatic hormone-sensitive prostate cancer (mHSPC) for decades. 1, 2 However, …
Androgen Deprivation Therapy for Advanced Prostate Cancer
Feb 3, 2025 · The Consumer’s Guide to Androgen Deprivation Therapy for Advanced Prostate Cancer This type of hormone therapy can help extend the lives of people who have metastatic …
Androgen deprivation therapy - Wikipedia
Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. …
Darolutamide in Combination With Androgen-Deprivation Therapy …
Sep 16, 2024 · Purpose: For patients with metastatic hormone-sensitive prostate cancer (mHSPC), delaying progression to castration-resistant disease is important not only for overall …
Metastatic Prostate Cancer: Androgen deprivation therapy
The German guideline for prostate cancer recommends androgen deprivation therapy for patients with a PSA doubling time <3 months, symptomatic local progression, proven distant …
Initial systemic therapy for advanced, recurrent, and metastatic ...
Jun 11, 2025 · These findings led to the development of androgen deprivation therapy (ADT) as the treatment for patients with advanced prostate cancer. Although ADT is palliative, it can …
ASCO GU 2025: Transdermal Oestradiol Patches as Androgen Deprivation ...
Dr. Nicholas James presented the results of a STAMPEDE trial platform study evaluating the efficacy and safety of combining transdermal estradiol patches, as androgen deprivation …